We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/8/2019 16:46 | I've forgotten. What's the potential timetable re the merger? | waterloo01 | |
05/8/2019 13:53 | Any day now | alphabravo321 | |
31/7/2019 16:17 | You are, chica1, like the rest of us an anonymous poster so I have no idea whether you are telling the truth, or not. I must admit to finding it strange that one who does "not own any stocks" should be posting on a bb of a site, ADVFN, that caters solely for private investors. I'm surprised you even bothered to look for the site. Of course you are entitled to your opinion and if you are telling the truth and have found, in your experience, that Episalvan is not that effective (if at all) you might be the exception that proves the rule. After all that's no doubt why AMYT had to increase the size of the phase III trial and increase the patient numbers. I doubt if there is any drug, or treatment, currently on sale that is effective for every patient. We'll have to await the final phase III results to find out whether your experiences (if you are being truthful) with Episalvan are the exception, or the norm! | papillon | |
31/7/2019 16:05 | mdalos1 31 Jul '19 - 00:19 - 4692 of 4693 0 0 0 POT KETTLE.... 100s of posts on here almost all of the time, relentlessly at times, including copy/pasting other people's posts AND having "arguments" here with Posters on an entirely different BB !!!! How ironic... LOLs Do you think you'll be down 65% or maybe as much as 75% when the dust settles ? >>>>> ROFLMAO. PMSL. I thought I'd copy your words of wisdom (LOL) for posterity before you delete them! I make no prediction of the likely share price when they relist, MADLOSS, unlike you! You have nailed your colours to the mast. When they relist I can refer to this post to see if you were right, or wrong! PS. Every time I post on this bb, you follow suit, MADLOSS. Are you stalking me? If you want to get to know me better just post me a message and we can arrange to meet up somewhere. We can then have a little chat! Close up and personal! LOL | papillon | |
31/7/2019 00:29 | I do not own any stocks. I am probably here for selfish reasons in the hope of relief for the condition that afflicts my family. | chica1 | |
30/7/2019 21:31 | PMSL. ROFLMAO. Okay, chica1. We've got the message! So you're doing your own single patient AP101 phase III trial. It's a shame that AMYT are conducting a phase III AP101 trial with circa 200 patients in different locations. How very wasteful of AMYT. They could have done a single patient phase III trial like yours and saved a fortune! PMSL ROFLMAO. 16 posts since you joined ADVFN in February of this year. All negative and all on AMYT. Don't you have any interest in other shares? How very strange! | papillon | |
30/7/2019 18:56 | Got our hands on some Episalvan again. Skin conditions tend to flair up in hot an clammy weather. We're not seeing ground breaking results. | chica1 | |
24/7/2019 11:18 | RNS targets early Q4 for re admission to AIM | alphabravo321 | |
22/7/2019 09:04 | thank you. Do we have any guestimate day for re-listing on AIM? | medicman1 | |
20/7/2019 23:49 | mdalos1 20 Jul '19 - 13:23 - 4684 of 4685 0 0 0 LOLs !! Nearly there now then... next step is realising approx. a 65% loss, unless a relatively brief opportunity to sell in the UK AIM Market avails itself before all instruments have been exercised and all Business deals are closed, with the consequences eventually hitting home hard. >>>>> So Nostradamus is predicting I will suffer a 65% loss on my AMYT shares. He obviously needs a new crystal ball as his present one is leading him astray. I'm hopeful that by listing on Nasdaq AMYT will receive the recognition it has sadly lacked on AIM. Biotechs are invariably much higher rated on Nasdaq than AIM. | papillon | |
20/7/2019 13:43 | Whoops Madloss.... forgot to take your olanzapine & resperidone tablets this morning? When you remember... you will likely start erasing your postings again! LOL! | diamondstar1 | |
20/7/2019 11:12 | Thanks for clarifying that, Strangeman. I was mystified, but then I have an excuse; I'm old. Apart from reading and posting on some ADVFN message boards I never use social media. Regarding LOL, I remember years ago David Cameron thought it meant "Lots of Love" when corresponding to his then horse riding pal, Rebekah Brooks. | papillon | |
19/7/2019 16:21 | "4 chars"?????????????? | papillon | |
19/7/2019 13:22 | same as the last 4 chars of your post. Another waste of bandwidth | strangeman | |
19/7/2019 10:07 | Yes, many thanks, alphabravo321, for posting that link. I also concur with delta0091. AMYT do appear to have got a bargain. Let's hope investors agree when AMYT relists on AIM and lists on NASDAQ. I was too late to read mdalos's words of wisdom as he'd already deleted his post by the time I looked at this bb. Did I miss much? LOL. | papillon | |
18/7/2019 21:28 | thanks alphabravo | bermudashorts | |
18/7/2019 15:48 | I have the exact same view! | alphabravo321 | |
18/7/2019 14:46 | if a fund manager had objection to the deal then it speaks volumes - they felt AMYT had got the acquisition on the cheap. AMYT seems to have pulled off a blinder here taking advantage of historical baggage affecting the company, yet buying a perfectly sound company. | delta0091 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions